METHODS: Using genome-wide association studies, we performed a two-sample Mendelian randomization (MR) analysis. In our analysis, the random-effects inverse variance weighted (IVW) method was predominantly employed, followed by several sensitivity analyses, which include heterogeneity, horizontal pleiotropy, outliers, and \"leave-one-out\" analyses.
RESULTS: The genetically predicted vitiligo was associated with an increased risk of rheumatoid arthritis (RA) (OR, 1.47; 95% confidence interval [CI], 1.29-1.68; p < 0.001), and systemic lupus erythematosus (SLE) (OR, 1.22; 95% CI, 1.06-1.39; p = 0.005). The causal associations were supported by sensitivity analyses. In Sjögren\'s syndrome and ankylosing spondylitis, no causal relationship with vitiligo was found in the study.
CONCLUSIONS: Our MR results support the causal effect that vitiligo leads to a higher risk of RA and SLE. Individuals with vitiligo should be vigilant for the potential development of RA and SLE. Managing and addressing this potential requires regular monitoring.
方法:使用全基因组关联研究,我们进行了双样本孟德尔随机化(MR)分析.在我们的分析中,主要采用随机效应逆方差加权(IVW)方法,随后进行了几次敏感性分析,其中包括异质性,水平多效性,异常值,和“留一法”分析。
结果:基因预测的白癜风与类风湿关节炎(RA)的风险增加有关(OR,1.47;95%置信区间[CI],1.29-1.68;p<0.001),和系统性红斑狼疮(SLE)(OR,1.22;95%CI,1.06-1.39;p=0.005)。因果关系得到敏感性分析的支持。在干燥综合征和强直性脊柱炎中,研究中未发现与白癜风的因果关系.
结论:我们的MR结果支持白癜风导致RA和SLE风险较高的因果效应。白癜风患者应警惕RA和SLE的潜在发展。管理和解决这一潜力需要定期监测。